Investing Ideas
/
Taiwanese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Taiwanese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Center Laboratories

Market Cap: NT$27.8b

A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

4123

NT$37.20

2.7%